Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jizhou Wang

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Nature Immunology|April 29, 2026
Kupffer cell calibration of T cell responses via VSIG4-CD5 interaction promotes tumor evasionXia Zhou, Wei Liu, Jing Hu, et al.
Ebiomedicine|June 10, 2019
NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathwaysFanzheng Meng, Shugeng Zhang, Ruipeng Song, et al.
Nature Cancer|June 4, 2025
RIOK1 phase separation restricts PTEN translation via stress granules activating tumor growth in hepatocellular carcinomaFanzheng Meng, Hairui Li, Yabin Huang, et al.
Journal of Hepatology|January 28, 2023
Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapyYao Liu, Zhenzhen Xun, Kun Ma, et al.
Theranostics|March 23, 2021
Inhibition of TGFβ1 accelerates regeneration of fibrotic rat liver elicited by a novel two-staged hepatectomyBo Zhang, Fanzheng Meng, Yao Liu, et al.
Hepatobiliary Surgery and Nutrition|September 22, 2025
Enhanced recovery after liver transplantation-a prospective analysis focusing on quality assessmentXiaodong Yuan, Jiwei Qin, Hao Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2019
A Novel Oxoglutarate Dehydrogenase-Like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and MetastasisYao Liu, Fanzheng Meng, Jiabei Wang, et al.
Bioscience Trends|December 25, 2024
Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition)Haowen Tang, Wenwen Zhang, Junning Cao, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Nature Immunology|April 29, 2026
Kupffer cell calibration of T cell responses via VSIG4-CD5 interaction promotes tumor evasionXia Zhou, Wei Liu, Jing Hu, et al.
Ebiomedicine|June 10, 2019
NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathwaysFanzheng Meng, Shugeng Zhang, Ruipeng Song, et al.
Nature Cancer|June 4, 2025
RIOK1 phase separation restricts PTEN translation via stress granules activating tumor growth in hepatocellular carcinomaFanzheng Meng, Hairui Li, Yabin Huang, et al.
Journal of Hepatology|January 28, 2023
Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapyYao Liu, Zhenzhen Xun, Kun Ma, et al.
Theranostics|March 23, 2021
Inhibition of TGFβ1 accelerates regeneration of fibrotic rat liver elicited by a novel two-staged hepatectomyBo Zhang, Fanzheng Meng, Yao Liu, et al.
Hepatobiliary Surgery and Nutrition|September 22, 2025
Enhanced recovery after liver transplantation-a prospective analysis focusing on quality assessmentXiaodong Yuan, Jiwei Qin, Hao Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2019
A Novel Oxoglutarate Dehydrogenase-Like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and MetastasisYao Liu, Fanzheng Meng, Jiabei Wang, et al.
Bioscience Trends|December 25, 2024
Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition)Haowen Tang, Wenwen Zhang, Junning Cao, et al.
Pageof 8